Back to Portfolio
RKLB

Rocket Lab USA

$90 49B market cap April 2026
Rocket Lab USA Inc RKLB BUFFETT / MUNGER / KLARMAN SUMMARY
1 SNAPSHOT
Price$90
Market Cap49B
2 BUSINESS

Rocket Lab is building the only credible end-to-end space company outside SpaceX, with a proven Electron launch vehicle (75+ missions, 100% success in 2025), a rapidly growing Space Systems division ($372M revenue, $1.3B in SDA contracts), and the Neutron medium-lift vehicle as high-risk optionality. The business quality is genuinely impressive — improving margins, massive backlog growth, and a founder-CEO who cut his own salary to $1. However, at ~$90/share and ~$49B market cap, the stock trades at ~80x trailing revenue for a company that lost $198M last year and burned $322M in cash. A sum-of-parts analysis values the proven businesses at ~$8B ($15/share) with Neutron optionality adding ~$4B risk-adjusted — totaling ~$12B or ~$22/share. The stock would need to decline 60-75% to offer a margin of safety appropriate for a pre-profit, high-execution-risk investment.

3 MOAT NARROW

Electron is the only proven dedicated small-sat launcher outside SpaceX. Regulatory barriers (launch licenses, range agreements) take 5-7 years to replicate. Space Systems vertical integration (SolAero solar panels, Sinclair reaction wheels, PSC separation systems) creates component-level switching costs. End-to-end space capability (launch + components + satellite prime) is unique outside SpaceX.

4 MANAGEMENT
CEO: Sir Peter Beck

Good/Aggressive - Strategic acquisitions (SolAero, Sinclair, PSC) built vertical integration. $1.15B ATM raise was rational capital-raising at elevated prices. Neutron capex managed within stated parameters.

5 ECONOMICS
-38% Op Margin
-9.8% ROIC
-11.5% ROE
-999x P/E
-0.32B FCF
-50.1% Debt/EBITDA
6 VALUATION
FCF Yield-0.65%
DCF Range22 - 35

Overvalued by 157-309%. Stock prices in near-perfect Neutron execution and sustained hypergrowth.

7 MUNGER INVERSION
Kill Event Severity P() E[Loss]
Neutron development risk: multiple delays, $360M+ spent, tank test failure, Q4 2026 target uncertain. Zero revenue from program. HIGH - -
SpaceX competitive dominance: Falcon 9 rideshare undercuts Electron pricing; Starship could collapse launch economics further. MED - -
8 KLARMAN LENS
Downside Case

Neutron development risk: multiple delays, $360M+ spent, tank test failure, Q4 2026 target uncertain. Zero revenue from program.

Why Market Right

Neutron test failure or further delays — would re-rate stock sharply lower; Continued dilution — 14% share count increase in 2025; Q1 2026 guides 605M weighted avg shares; SpaceX Starship operational success — could compress launch pricing across industry; Government budget cuts — SDA contract concentration creates political risk

Catalysts

Neutron maiden flight success (Q4 2026 target) — would validate $40B+ of market cap; SDA contract execution — $1.3B in government satellite work builds prime contractor credibility; Space Systems margin expansion — Q4 2025 non-GAAP gross margin hit 44.3%; Path to adj. EBITDA breakeven — could accelerate if Neutron capex peaks in 2026

9 VERDICT WAIT
B- Quality Moderate - $1B+ cash pile (thanks to $1.15B ATM raise) provides ~3 years runway at current burn. But negative FCF of -$322M/yr and ongoing Neutron capex pressure.
Strong Buy$20
Buy$30
Fair Value$35

Monitor for significant pullback. Accumulate zone is $28-35. Do not initiate position at current prices.

🧠 ULTRATHINK Deep Philosophical Analysis

Rocket Lab (RKLB) — Ultrathink: The Second Rocketeer's Dilemma

The Core Question

Is Rocket Lab building the next great industrial franchise, or is it the best house in a neighborhood that SpaceX already owns?

This is the essential tension in the RKLB thesis. Peter Beck has built something genuinely remarkable — the only company besides SpaceX that can design a satellite, manufacture its components, build the spacecraft, and launch it to orbit on its own rocket. That vertical integration is not marketing fluff. It is real, it is operational, and it is getting better every quarter. The 2025 results prove it: $602 million in revenue, 38% growth, improving gross margins, a $1.85 billion backlog, and the second most frequently launched orbital rocket in the United States.

But here is the uncomfortable truth that the market is choosing to ignore: none of this makes the stock cheap. Or even fairly valued. Or even within the same zip code as fairly valued.

Moat Meditation

Electron has a moat, and it is narrower but more durable than most people realize. The moat is not technological — anyone with enough money and engineers can theoretically build a small rocket. The moat is regulatory, operational, and reputational. Launch licenses take years. Range agreements with government facilities take years. Building a track record of 75+ successful missions takes years. And customers making hundred-million-dollar satellite bets do not experiment with unproven launch providers.

This is the same moat structure that protects defense primes — not a single brilliant innovation, but an accumulation of certifications, relationships, track record, and institutional trust that would take a new entrant a decade to replicate. Rocket Lab has spent seventeen years building this position. The barriers are real.

Space Systems adds a different moat dimension. Through acquisitions of SolAero, Sinclair, and PSC, Rocket Lab now controls critical spacecraft components — solar panels, reaction wheels, star trackers, separation systems — that most satellite manufacturers must purchase from third parties. This creates both switching costs and intelligence advantages. When you build the components AND the satellite AND the rocket, you understand the full system in ways your competitors cannot. This is what made SpaceX so effective with Starlink — complete vertical integration from silicon to orbit.

But Neutron? Neutron has no moat. Not yet. It is a development program competing against the most successful rocket company in human history. SpaceX launches Falcon 9 roughly every three days with routine reliability. Neutron has never left the ground. The propellant tank failed during testing. The timeline has slipped from 2024 to Q4 2026. The development cost has grown from $250 million to $360 million and counting.

This is not unusual for rocket programs. What is unusual is the market assigning roughly $40 billion of value to a rocket that does not exist yet.

The Owner's Mindset

Would Buffett own Rocket Lab for twenty years? Almost certainly not at this price, and probably not at any price. This is not a Buffett business. It has no earnings, no cash flow, no dividend, no pricing power (yet), and it depends on the successful development of a new rocket — which is about as far from "within my circle of competence" as Buffett could imagine.

But Beck himself passes the owner-operator test with flying colors. He founded the company at age twenty-eight with essentially no formal aerospace education. He personally designed Electron's Rutherford engine. He moved the company from New Zealand to the US to access government contracts. He executed a SPAC merger, then pivoted to building a full space systems platform through acquisitions. And in March 2026, he cut his salary to one dollar and cancelled nearly four hundred thousand unvested RSUs.

This is not a hired-gun CEO optimizing for the next quarter. This is a founder who believes in the mission and is willing to sacrifice personal compensation to fund it. That kind of alignment is rare and valuable — but it does not make the stock cheap.

Risk Inversion

What could destroy Rocket Lab? Three scenarios deserve serious consideration.

First, SpaceX Starship achieves full reusability and dramatically collapses launch costs. If Starship can launch payloads for one-tenth the cost of Falcon 9, the entire commercial launch market restructures around SpaceX. Electron becomes a premium niche product for customers who need specific orbits and cannot wait for rideshare windows. Neutron becomes economically uncompetitive before it even launches. This is the existential scenario, and it is not implausible.

Second, Neutron fails — not the program, but the first flight. A spectacular failure would not kill the company (SpaceX blew up many rockets before Falcon 9 worked), but it would destroy the narrative that supports a $49 billion market cap. The stock could easily halve on a failed maiden flight, even if the engineering team learns from the failure and succeeds on the next attempt.

Third, prolonged cash burn with continued dilution. At negative $322 million in annual free cash flow and a track record of massive ATM raises, the dilution math is punishing. If the company needs to raise another billion dollars before reaching profitability, existing shareholders face another 10-15% dilution. At $90 per share, you are paying a premium for shares that are being created at an alarming rate.

Valuation Philosophy

Here is the fundamental problem with RKLB at $90: the stock market is treating a pre-profit company with $602 million in revenue as if it were a proven franchise worth $49 billion. That is roughly 80 times trailing revenue.

For context, even the most aggressive growth investors typically apply 20-30x revenue to high-growth software companies with 80%+ gross margins, negative churn, and proven unit economics. Rocket Lab has 34% gross margins, significant hardware costs, unproven unit economics on its key growth vehicle, and a business model that requires building physical rockets — not copying software.

A rigorous sum-of-parts analysis values the proven businesses (Electron + Space Systems + net cash) at roughly $8 billion, or about $15 per share. Adding risk-adjusted Neutron optionality (say, 40% probability of capturing $2B in annual revenue by 2030 at reasonable margins) adds perhaps $4 billion more. Total: approximately $12 billion, or $22 per share.

The market is paying four times this amount. That is not a margin of safety. That is a margin of speculation.

The Patient Investor's Path

Rocket Lab is the kind of company you want to own at the right price. The business is real. The moat is forming. The founder is exceptional. The TAM is enormous and growing. If Neutron works, if Space Systems continues to scale, if the company reaches profitability — this could be a fifty-billion-dollar company someday. Maybe even a hundred-billion-dollar company.

But someday is not today. And the market is pricing in someday as if it were a certainty.

The patient investor's path is clear: admire the business, study the quarterly results, wait for the price to come to you. The entry will come. It always does. A Neutron test failure. A broader market sell-off. A quarter of decelerating growth. A capital raise at a moment of weakness. Space stocks are among the most volatile on the market precisely because they are priced on dreams rather than cash flows.

When the stock revisits the $28-35 range — which it traded at as recently as mid-2025 — you would be buying the proven Electron franchise, the growing Space Systems business, and getting Neutron optionality essentially for free. That is the kind of asymmetric bet that builds wealth over decades.

At $90, you are paying for the dream in full, plus a premium for the privilege of holding it. That is not investing. That is speculation with a compelling narrative.

Wait for the price. The rockets will still be there.

Executive Summary

Rocket Lab is the only credible end-to-end space company outside of SpaceX. With a proven Electron small-launch vehicle (second most frequently launched US orbital rocket), a rapidly growing Space Systems division (satellite components and full spacecraft), and the high-risk/high-reward Neutron medium-lift vehicle in development, RKLB represents a unique pure-play on the accelerating space economy. The business is real and growing fast — FY2025 revenue of $602M (+38% YoY), backlog of $1.85B (+73% YoY) — but the stock at ~$90 prices in extraordinary execution on Neutron and sustained hypergrowth. At current levels, the stock trades at ~80x trailing revenue and is deeply unprofitable. This is a high-quality growth story with a legitimate moat, but the valuation leaves no room for error.

Phase 1: Risk Assessment

Critical Risks

1. Neutron Development Risk (SEVERE) Neutron is the linchpin of Rocket Lab's long-term thesis. This medium-lift, partially reusable vehicle is designed to compete with SpaceX's Falcon 9 for commercial and government payloads. But it remains in development after multiple delays:

  • Original target: mid-2024. Current target: Q4 2026.
  • A stage 1 propellant tank failed during testing, pushing the timeline further right.
  • Total development spend through end-2025: ~$360M, well above the original $250-300M estimate.
  • Neutron has generated zero revenue. Every dollar spent is a sunk cost if the program fails.
  • Rocket development has historically high failure rates. Even successful programs (Falcon 9, Vulcan) experienced multiple delays and failures before operational readiness.

2. SpaceX Competitive Dominance SpaceX is to launch what Google is to search — a dominant incumbent with massive scale advantages. Falcon 9 offers rideshare at $5,000-6,000/kg, dramatically undercutting Electron's ~$27,000/kg. SpaceX's Starship, if successful, could further collapse launch economics. Rocket Lab must compete on dedicated launch timing and flexibility, not price.

3. Cash Burn and Dilution

  • FY2025 operating cash flow: -$165.5M
  • FY2025 capex: -$156.3M (total cash burn from operations + capex: ~$322M)
  • The company raised $1.15B via ATM equity offerings in 2025, massively diluting shareholders.
  • Weighted average shares increased from ~500M (FY2024) to 531M (FY2025), with Q1 2026 guidance citing 605M weighted average shares — a 14% increase in a single year.
  • Convertible notes of $152.4M add further potential dilution.

4. Government Contract Concentration The $816M SDA prime contract and $515M SDA Tranche 2 contract together represent ~$1.3B — roughly 70% of the $1.85B backlog. Government programs can be delayed, restructured, or cancelled. Budget sequestration, political shifts, or program re-scoping are ever-present risks.

5. Key Person Risk Peter Beck is the visionary founder, CEO, and technical leader. His March 2026 decision to reduce his salary to $1 and cancel 392K RSUs signals alignment, but it also highlights how deeply the company's identity is tied to one individual. Beck holds 51M shares (9.8% voting power) through his Equatorial Trust, primarily in Series A Preferred stock.

6. Launch Failure Risk Any Electron mission failure would damage reputation and cause revenue loss. A Neutron failure on maiden flight — while expected in the industry — could crater the stock given how much of the valuation depends on Neutron's success.

Secondary Risks

  • Tariff/trade risk: Components sourced globally; New Zealand manufacturing exposed to trade policy shifts.
  • Supply chain: Rocket engines (Rutherford, Archimedes) are manufactured in-house, reducing but not eliminating supply risk.
  • Integration risk: Multiple acquisitions (Sinclair, SolAero, PSC, Mynaric stake) must be integrated while growing rapidly.

Phase 2: Financial Analysis

Revenue Trajectory

Year Revenue ($M) YoY Growth
2022 211.0 —
2023 244.6 +15.9%
2024 436.2 +78.3%
2025 601.8 +38.0%
Q1 2026E 185-200 +57% YoY

Revenue has accelerated meaningfully, with Q1 2026 guidance implying annualized ~$770M+ run-rate.

Segment Breakdown (FY2025)

  • Product revenues (Space Systems): $371.6M (62% of total)
  • Service revenues (Launch Services): $230.2M (38% of total)

Space Systems is now the larger segment, driven by satellite manufacturing contracts (SDA, Globalstar, Varda). Launch Services grew but remains the smaller contributor. In Q3 2025, Space Systems delivered $114.2M vs Launch's $40.9M — a 74%/26% split.

Margin Profile

Metric FY2024 FY2025 Q4 2025
GAAP Gross Margin 26.6% 34.4% 37.9%
Non-GAAP Gross Margin — — 44.3%
Operating Margin -43.5% -38.0% -28.4%

Gross margins are improving rapidly — from 26.6% to 34.4% in one year, with Q4 2025 at 37.9% (non-GAAP 44.3%). This reflects better Space Systems mix and Electron pricing power. However, the company remains deeply unprofitable at the operating level due to heavy R&D (Neutron) and SGA spending.

Profitability (or Lack Thereof)

Metric FY2024 FY2025
Net Loss -$190.2M -$198.2M
Loss Per Share -$0.38 -$0.37
Adj. EBITDA -$96.9M -$101.2M
Operating Cash Flow -$48.9M -$165.5M

The net loss widened slightly despite strong revenue growth, because Neutron development spending and ATM dilution costs outpaced margin improvement. Operating cash flow deteriorated significantly from -$48.9M to -$165.5M.

Balance Sheet (Dec 31, 2025)

Strengths:

  • Cash + marketable securities: $1,016.6M ($828.7M cash + $187.9M securities)
  • Total stockholders' equity: $1,721.9M
  • Debt: Only $152.4M in convertible notes + $1.7M long-term borrowings

Concerns:

  • Accumulated deficit: -$1,011.9M
  • Goodwill + intangibles: $430.5M (from acquisitions)
  • At current burn rate (~$165M/yr operating + $156M capex), the $1B+ cash pile provides ~3 years of runway. But Neutron capex is accelerating.

Net cash position: ~$862M (cash + securities - convertible notes). This is a strong balance sheet for a pre-profit growth company, largely thanks to the $1.15B ATM raise.

Backlog

$1.85B as of Dec 31, 2025 (+73% YoY). Split: ~74% Space Systems, ~26% Launch. Management expects ~37% conversion within 12 months, implying ~$685M in near-term revenue visibility. This covers Q1 2026 guidance comfortably and provides multi-year runway.

Phase 3: Moat Assessment

Electron Launch Vehicle — Narrow Moat (Proven)

Electron is the only operational dedicated small-satellite launch vehicle with a meaningful track record outside of SpaceX. Key moat attributes:

  • 75+ successful missions through end of 2025, with 100% success in 2025 (21 launches).
  • Second most frequently launched US orbital rocket after Falcon 9.
  • Dedicated launch: Unlike SpaceX rideshare, Electron offers custom orbits and schedules. Customers pay a premium for flexibility.
  • Two launch pads: Mahia (New Zealand) and Wallops Island (Virginia) — geographic diversity and access to different orbital inclinations.
  • Regulatory moat: Launch licenses, range agreements, and safety certifications take years to obtain. New entrants face 5-7 year regulatory timelines.
  • In-house engine manufacturing: Rutherford engines are 3D-printed in-house, controlling cost and supply.

Limitation: Electron addresses only the small-sat market (~$1-2B TAM). It cannot scale to larger payloads. At ~$7.5M per launch, it generates ~$160-230M annually — meaningful but insufficient to justify a $49B market cap.

Space Systems — Emerging Moat (Growing)

This is where the vertical integration thesis becomes compelling:

  • Component monopolies: SolAero (satellite solar panels), Sinclair (reaction wheels, star trackers), PSC (separation systems) — each has limited competition.
  • Prime contractor capability: The $816M SDA contract proves Rocket Lab can win and execute as a satellite prime, competing with Northrop Grumman, L3Harris, and Ball Aerospace.
  • Vertical integration: Launch + spacecraft components + satellite design/build = end-to-end solution. No other company besides SpaceX offers this.
  • 2,600+ employees with deep space systems expertise across US, NZ, and Canada.

Neutron — No Moat (Optionality)

Neutron has zero moat today. It is an R&D project competing against:

  • SpaceX Falcon 9 (proven, reusable, dominant)
  • ULA Vulcan (operational)
  • Blue Origin New Glenn (in testing)
  • Arianespace Ariane 6 (operational but struggling)

If Neutron works and achieves reusability, it could capture a meaningful share of the $10B+ medium-to-heavy launch market. But this is a big "if" — the market is pricing in success before it happens.

Overall Moat Rating: NARROW (Electron + Space Systems proven; Neutron unproven)

Phase 4: Valuation and Synthesis

The Valuation Problem

At ~$90/share and ~$49B market cap (using ~544M diluted shares), RKLB trades at:

Metric Value
EV/Revenue (TTM) ~80x
EV/Revenue (2026E ~$900M) ~53x
EV/Backlog ~26x
P/Book ~28x

These are extraordinary multiples. For context:

  • SpaceX (private) was reportedly valued at ~$350B on ~$15B revenue = ~23x revenue
  • L3Harris: ~2.5x revenue
  • Northrop Grumman: ~1.8x revenue
  • Even Palantir at peak hype traded at ~40x revenue

Sum-of-Parts Framework

Electron Launch (~$230M revenue, growing 15-20%/yr): At 15x revenue (generous for a niche launcher) = ~$3.5B

Space Systems (~$370M revenue, growing 30-40%/yr): At 10x revenue (in line with defense/space contractors at premium) = ~$3.7B

Net Cash: ~$862M

Subtotal (proven businesses): ~$8.1B or ~$15/share

Neutron Optionality: The market is assigning ~$41B (!!!) to Neutron optionality — a vehicle that has never flown, has slipped multiple times, and faces competition from the most successful rocket company in history.

Even if Neutron captures 20% of the $10B addressable medium-launch market by 2030 ($2B revenue) at 25% margins ($500M EBITDA), a 20x EBITDA multiple = $10B. Risk-adjusted at 40% probability of success = $4B.

Total sum-of-parts: ~$12B or ~$22/share. The market is paying 4x this.

Path to Profitability

Management has not provided a profitability timeline. Best case scenario:

  • FY2026: Revenue $900M+, continued adj. EBITDA losses but narrowing
  • FY2027: If Neutron launches successfully and Space Systems scales, potential for breakeven adj. EBITDA
  • FY2028-2029: First GAAP profitability possible if Neutron achieves operational cadence

What the Stock Is Pricing In

At $90/share, the market is pricing in:

  1. Neutron succeeds on first or second attempt (historically unlikely)
  2. Revenue grows to $3-5B by 2030 (requires Neutron + massive Space Systems scaling)
  3. Margins expand to 20-25% EBITDA (requires launch reusability)
  4. Limited further dilution (contradicted by 14% dilution in 2025 alone)
  5. No significant competition from SpaceX Starship or Blue Origin New Glenn

This is a "priced to perfection" scenario with limited margin of safety.

Entry Price Framework

Level Price Implied Market Cap Rationale
Strong Buy $18-22 ~$10-12B Proven businesses at fair value + modest Neutron option
Accumulate $28-35 ~$15-19B Reasonable premium for growth trajectory
Fair Value $45-55 ~$25-30B Full value for proven + discounted Neutron
Current ~$90 ~$49B Prices in near-perfect Neutron execution

Management Assessment

Peter Beck is an exceptional founder — a self-taught rocket engineer from New Zealand who built the second most active orbital launch company in the US from scratch. His March 2026 decision to cut his salary to $1 and cancel RSUs demonstrates genuine commitment. CFO Adam Spice provides solid financial discipline from his semiconductor industry background.

However, the ATM equity raises ($1.15B in 2025) signal that management knows the stock is overvalued and is using it as cheap currency — rational but dilutive to existing shareholders.

Verdict

Rating: WAIT

Rocket Lab is a genuinely excellent company — one of the few pure-play space stocks with real revenue, real contracts, a proven launch vehicle, and a credible path to becoming the #2 end-to-end space company behind SpaceX. Peter Beck is a world-class founder-CEO.

But excellence and a good investment are not the same thing. At ~$90/share and ~$49B market cap, the stock prices in flawless Neutron execution, sustained 30%+ revenue growth for years, eventual profitability, and limited dilution — none of which are guaranteed.

The sum-of-parts analysis suggests fair value around $22-35/share for proven businesses plus risk-adjusted Neutron optionality. The stock would need to decline 60-75% from current levels to offer a genuine margin of safety.

Action: Monitor for significant pullback. A Neutron test failure, broader market correction, or growth deceleration could create entry opportunities. The $28-35 range would represent a reasonable accumulate zone where you are paying a fair premium for quality growth without requiring perfection.

Strong Buy: $20 | Accumulate: $30 | Current: $90